Rob Myers

Rob Myers, MD, currently serves as the Chief Medical Officer and Head of Development at OrsoBio since February 2022. Prior to this role, Rob Myers worked at Gilead Sciences from February 2015 to February 2022, holding positions as Vice President of the Liver Fibrosis and Inflammatory Bowel Disease Therapeutic Area and Senior Director of the Liver Diseases Therapeutic Area. Rob Myers also contributed to the field of hepatology as an Associate Professor at the Liver Unit, University of Calgary, from January 2003 to February 2015.